Ginsenoside Rb1 attenuates diabetic retinopathy in streptozotocin-induced diabetic rats

Abstract

Purpose To investigated the effects of ginsenoside Rb1 on diabetic retinopathy in streptozotocin-induced diabetic rats. Methods Diabetes was induced by a single intraperitoneal injection of streptozotocin (80 mg/kg) in male Wistar rats. Ginsenoside Rb1 (20, 40 mg/kg) was injected (i.p.) once a day for 4 weeks. Then, using fundus photography, the diameter and vascular permeability of retinal vessels were investigated. Retinal histopathology was undertaken. Contents of malondialdehyde (MDA) and glutathione (GSH) in retinas were assayed. Levels of nuclear factor erythroid 2-related factor 2 (Nrf2), glutathione cysteine ligase catalytic subunit (GCLC), and glutathione cysteine ligase modulatory subunit (GCLM) were measured. Results Treatment with ginsenoside Rb1 attenuated the diabetes-induced increase in the diameter of retinal blood vessels. Ginsenoside Rb1 reduced extravasation of Evans Blue dye from retinal blood vessels. Ginsenoside Rb1 partially inhibited the increase in MDA content and decrease in GSH level in rat retinas. Nrf2 levels in the nuclei of retinal cells and expression of GCLC and GCLM were increased significantly in rats treated with ginsenoside Rb1. Conclusion These findings suggest that ginsenoside Rb1 can attenuate diabetic retinopathy by regulating the antioxidative function in rat retinas.

Ginsenoside Rb1 Improves Cognitive Impairment Induced by Insulin Resistance through Cdk5/p35-NMDAR-IDE Pathway

“…Although studies using ginsenoside Rb1 on AD advanced our knowledge in revealing the pathology of AD, the possible mechanism involved still remains unclear. In addition, there are documents that support the benefits of ginsenoside Rb1 in antiobesity, antihyperglycaemic, and antidiabetic effects by regulating the metabolism of a glycolipid and improvement of insulin sensitivity [18][19], but the mechanism involved still remains largely unknown and awaits further exploration.…”

The promising therapeutic potentials of ginsenosides mediated through p38 MAPK signaling inhibition

“…[ 87 ]. Ginsenoside Rb 1 showed a significant role in the management of several ailments such as diabetes [ 88 ], CKD-associated vascular calcification [ 89 ], myocardial infarction [ 90 ], diabetic retinopathy [ 91 ], cognitive impairment [ 92 ], heart arrythmia [ 93 ], acetaminophen-induced hepatotoxicity [ 94 ], cisplatin-induced memory impairment [ 95 ] and others.…”

Potential Protective and Therapeutic Roles of the Nrf2 Pathway in Ocular Diseases: An Update

“…Diabetes rat retinas Increases the expression of Nrf2, GCLC, and GCLM [226] Pyridoxamine Retinal photoreceptor cells Partly protects cells against light damage by Nrf2 expression [227] Scutellarin (SC)…”